Lisanti Capital Growth’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-125,350
| Closed | -$10.9M | – | 145 |
|
|
2021
Q2 | $10.9M | Buy |
125,350
+113,555
| +963% | +$9.86M | 1.35% | 18 |
|
|
2021
Q1 | $972K | Buy |
+11,795
| New | +$972K | 0.12% | 117 |
|
|
2020
Q2 | – | Sell |
-14,780
| Closed | -$328K | – | 127 |
|
|
2020
Q1 | $328K | Buy |
+14,780
| New | +$328K | 0.11% | 112 |
|
|
2019
Q4 | – | Sell |
-125,060
| Closed | -$1.94M | – | 117 |
|
|
2019
Q3 | $1.94M | Buy |
125,060
+63,445
| +103% | +$985K | 0.63% | 64 |
|
|
2019
Q2 | $1.25M | Sell |
61,615
-117,175
| -66% | -$2.38M | 0.41% | 78 |
|
|
2019
Q1 | $3.14M | Buy |
178,790
+36,030
| +25% | +$633K | 1.11% | 34 |
|
|
2018
Q4 | $1.83M | Buy |
+142,760
| New | +$1.83M | 0.74% | 56 |
|